Search research articles
Contact Us
Filters
Showing results (101-110 of 426) with videos related to
Page
of 43
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
October 1, 1979
Activation of complement by Schistosoma mansoni schistosomula: killing of parasites by the alternative pathway and requirement of IgG for classical pathway activation
F Santoro, P J Lachmann, A Capron, et al.
Immunology
|
February 1, 1992
The targeting of T-helper cells and tumourcidal macrophages to a B-cell lymphoma using a PPD-monoclonal antibody heteroconjugate
A M Montgomery, M G Wing, P J Lachmann
International Archives of Allergy and Applied Immunology
|
January 1, 1980
The coagglutination phenomenon of Bordet and Gengou involves a reaction between antibody-aggregated fourth component of complement and a receptor on guniea pig red cells
R R Coombs, A B Wilson, P J Lachmann
Rheumatology (Oxford, England)
|
March 25, 2025
Systemic autoinflammatory disease diagnoses in a single year from a UK national referral centre
Hugh Caterson, Charalampia Papadopoulou, Claire Peet, et al.
The Biochemical Journal
|
May 15, 1988
Analysis of the interactions between properdin, the third component of complement (C3), and its physiological activation products
T C Farries, P J Lachmann, R A Harrison
Biological Trace Element Research
|
July 1, 1989
Inhibition by metals of X-ray and ultraviolet-induced DNA repair in human cells
R D Snyder, G F Davis, P J Lachmann
The Journal of Experimental Medicine
|
May 1, 1975
The mechanism of action of the C3b inactivator (conglutinogen-activating factor) on its naturally occurring substrate, the major fragment of the third component of complement (C3b)
J D Gitlin, F S Rosen, P J Lachmann
The Journal of Experimental Medicine
|
May 1, 1994
Functional and antigenic similarities between a 94-kD protein of Schistosoma mansoni (SCIP-1) and human CD59
M Parizade, R Arnon, P J Lachmann, et al.
Journal of Immunological Methods
|
August 30, 1992
A cleavable biotinylating agent and its use in protein electroblots
M J Hobart, B A Fernie, P J Lachmann
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
February 1, 1993
Peripheral blood mononuclear cells from house dust mite allergic patients produce IL-2 in response to specific allergen challenge
S M McHugh, P J Lachmann, P W Ewan
Page
of 43
Search research articles
Search
Showing results (101-110 of 426) with videos related to
Sort By:
Page
of 43
Journal of Immunology (Baltimore, Md. : 1950)
|
October 1, 1979
Activation of complement by Schistosoma mansoni schistosomula: killing of parasites by the alternative pathway and requirement of IgG for classical pathway activation
F Santoro, P J Lachmann, A Capron, et al.
Immunology
|
February 1, 1992
The targeting of T-helper cells and tumourcidal macrophages to a B-cell lymphoma using a PPD-monoclonal antibody heteroconjugate
A M Montgomery, M G Wing, P J Lachmann
International Archives of Allergy and Applied Immunology
|
January 1, 1980
The coagglutination phenomenon of Bordet and Gengou involves a reaction between antibody-aggregated fourth component of complement and a receptor on guniea pig red cells
R R Coombs, A B Wilson, P J Lachmann
Rheumatology (Oxford, England)
|
March 25, 2025
Systemic autoinflammatory disease diagnoses in a single year from a UK national referral centre
Hugh Caterson, Charalampia Papadopoulou, Claire Peet, et al.
The Biochemical Journal
|
May 15, 1988
Analysis of the interactions between properdin, the third component of complement (C3), and its physiological activation products
T C Farries, P J Lachmann, R A Harrison
Biological Trace Element Research
|
July 1, 1989
Inhibition by metals of X-ray and ultraviolet-induced DNA repair in human cells
R D Snyder, G F Davis, P J Lachmann
The Journal of Experimental Medicine
|
May 1, 1975
The mechanism of action of the C3b inactivator (conglutinogen-activating factor) on its naturally occurring substrate, the major fragment of the third component of complement (C3b)
J D Gitlin, F S Rosen, P J Lachmann
The Journal of Experimental Medicine
|
May 1, 1994
Functional and antigenic similarities between a 94-kD protein of Schistosoma mansoni (SCIP-1) and human CD59
M Parizade, R Arnon, P J Lachmann, et al.
Journal of Immunological Methods
|
August 30, 1992
A cleavable biotinylating agent and its use in protein electroblots
M J Hobart, B A Fernie, P J Lachmann
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
February 1, 1993
Peripheral blood mononuclear cells from house dust mite allergic patients produce IL-2 in response to specific allergen challenge
S M McHugh, P J Lachmann, P W Ewan
Page
of 43